Monarch Medical Technologies, based in Charlotte, NC, is a leading provider of precision insulin dosing technology through their EndoTool Glucose Management System. Their software is designed to improve patient outcomes by offering personalized and predictive insulin dosing across the healthcare enterprise, catering to medically complex patients with various conditions such as renal impairment and steroid exposure.
Hospitals utilizing Monarch Medical Technologies' EndoTool have reported reduced risk of hypoglycemia, improved compliance in managing hyperglycemia, and better patient outcomes, including shorter ICU stays and decreased instances of hyperglycemia. The company's proven algorithms adapt dosing recommendations to individual patient responses, ensuring more precise and safer therapy for inpatient glycemic management.
Generated from the website